ESMO 2026: Oncology Post Conference Report

The ESMO 2026 Oncology Post-Conference Report brings the key Oncology therapeutic developments together in one place, translating the data presented at the congress into a clear view of the drug development trends shaping the oncology landscape. From the growing momentum behind ADCs and bispecifics to evolving biomarker strategies and potentially practice-changing readouts, the report helps you quickly understand where the field is moving and what deserves closer attention.

The ESMO 2026 Post Conference Report

The Report Includes:

  • The modalities and disease areas driving oncology development, helping you understand where clinical activity and innovation are concentrating.
  • The targets and combination strategies gaining momentum, including the growing role of ADCs, bispecifics and novel multi-mechanistic approaches.
  • How the clinical trial landscape is evolving, from disease and phase trends to emerging biomarkers, first-in-trial readouts and the most active sponsors.
  • Ten priority ESMO readouts to have on your radar, highlighting results with the potential to influence treatment practice, sequencing and technology validation.
Oncology ESMO 2026 Landing Page Image

Download The ESMO 2026 Post Conference Report

Please complete the form to download The ESMO 2026 Post Conference Report

 

You May Also Be Interested In…

Learn More About Oncology

What is Beacon Oncology?
  • The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
  • Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Oncology Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search